Interventions to improve HPV vaccine uptake: A systematic review

Pediatrics

Volumn 138, Issue 1, 2016, Pages

  Walling, Emily B ^a   Benzoni, Nicole ^b   Dornfeld, Jarrod ^b   Bhandari, Rusha ^b   Sisk, Bryan A ^b   Garbutt, Jane ^b,c   Colditz, Graham ^d  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b School of Medicine   (United States)

^c EMORY UNIVERSITY   (United States)

^d WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

CANCER PREVENTION; CONDYLOMA ACUMINATUM; DRUG UTILIZATION; ECONOMIC ASPECT; HEALTH BEHAVIOR; HEALTH CARE AVAILABILITY; HEALTH CARE POLICY; HEALTH EDUCATION; HEALTH PROGRAM; HEALTH PROMOTION; HUMAN; MEDICAL INFORMATION; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; SYSTEMATIC REVIEW; VACCINATION; ADOLESCENT; ADULT; CHILD; HEALTH CARE DELIVERY; MASS IMMUNIZATION; PATIENT ATTITUDE; PROCEDURES; UTILIZATION; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; HEALTH PROMOTION; HEALTH SERVICES ACCESSIBILITY; HUMANS; MASS VACCINATION; PAPILLOMAVIRUS VACCINES; PATIENT ACCEPTANCE OF HEALTH CARE; YOUNG ADULT;

EID: 84976873329     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2015-3863     Document Type: Review

References (82)

1. Rimer BK, Harper H, Witte ON; President's Cancer Panel. Accelerating HPV Vaccine Uptake: Urgency for Action to Prevent Cancer. Available at: Http://deainfo. nci. nih.gov/advisory/pcp/annualReports/HPV/PDF/PCP-Annual-Report-2012-2013.pdf. Accessed April 24, 2016
2. Cancer of the Cervix Uteri-SEER Stat Fact Sheets. http://seer. cancer.gov/statfacts/html/cervix.html. Accessed August 28, 2015
3. World Health Organization. Human papillomavirus (HPV) and cervical cancer. Available at: Www.who. int/mediacentre/factsheets/fs380/en/. Accessed August 28, 2015
4. Vaccines: VPD-VAC/HPV/Vaccine FAQ. Available at: Www.cdc.gov/vaccines/vpd-vac/hpv/vac-faqs.htm#vaccine. Accessed August 28, 2015
5. Dillner J, Kjaer SK, Wheeler CM, et al; FUTURE I/II Study Group. Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: Randomised controlled trial. BMJ. 2010;341: C3493
6. Giuliano AR, Palefsky JM, Goldstone S, et al. Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males. N Engl J Med. 2011;364(5): 401-411
7. Reagan-Steiner S, Yankey D, Jeyarajah J, et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years-United States, 2014. MMWR Morb Mortal Wkly Rep. 2015;64(29): 784-792
8. Browse the SEER Cancer Statistics Review 1975-2012. Available at: Http://seer. cancer.gov/csr/1975-2012/browse-csr. php? sectionSEL=5& pageSEL=sect-05-Table. 11.html. Accessed September 8, 2015
9. Sheppard C, El-Zein M, Ramanakumar AV, Ferenczy A, Franco EL. Assessment of mediators of racial disparities in cervical cancer survival in the United States. Int J Cancer. January 2016;138(11): 2622-2630
10. Mehta P, Sharma M, Lee RC. Designing and evaluating a health belief modelbased intervention to increase intent of HPV vaccination among college males. Int Q Community Health Educ. 2013-2014;34(1): 101-117
11. Paiva AL, Lipschitz JM, Fernandez AC, Redding CA, Prochaska JO. Evaluation of the acceptability and feasibility of a computer-Tailored intervention to increase human papillomavirus vaccination among young adult women. J Am Coll Health. 2014;62(1): 32-38
12. Reiter PL, Stubbs B, Panozzo CA, Whitesell D, Brewer NT. HPV and HPV vaccine education intervention: Effects on parents, healthcare staff, and school staff. Cancer Epidemiol Biomarkers Prev. 2011;20(11): 2354-2361
13. Kester LM, Shedd-Steele RB, Dotson-Roberts CA, Smith J, Zimet GD. The effects of a brief educational intervention on human papillomavirus knowledge and intention to initiate HPV vaccination in 18-26 year old young adults. Gynecol Oncol. 2014; 132(suppl 1): S9-S12
14. Perkins RB, Clark JA. What affects human papillomavirus vaccination rates? A qualitative analysis of providers' perceptions. Womens Health Issues. 2012;22(4): E379-e386
15. Rosenthal SL, Weiss TW, Zimet GD, Ma L, Good MB, Vichnin MD. Predictors of HPV vaccine uptake among women aged 19-26: Importance of a physician's recommendation. Vaccine. 2011;29(5): 890-895
16. Sussman AL, Helitzer D, Sanders M, Urquieta B, Salvador M, Ndiaye K. HPV and cervical cancer prevention counseling with younger adolescents: Implications for primary care. Ann Fam Med. 2007;5(4): 298-304
17. Thompson VLS, Arnold LD, Notaro SR. African American parents' attitudes toward HPV vaccination. Ethn Dis. 2011;21(3): 335-341
18. Gottvall M, Tydén T, Höglund AT, Larsson M. Knowledge of human papillomavirus among high school students can be increased by an educational intervention. Int J STD AIDS. 2010;21(8): 558-562
19. Holman DM, Benard V, Roland KB, Watson M, Liddon N, Stokley S. Barriers to human papillomavirus vaccination among US adolescents: A systematic review of the literature. JAMA Pediatr. 2014;168(1): 76-82
20. Fu LY, Bonhomme L-A, Cooper SC, Joseph JG, Zimet GD. Educational interventions to increase HPV vaccination acceptance: A systematic review. Vaccine. 2014;32(17): 1901-1920
21. Niccolai LM, Hansen CE. Practice-And community-based interventions to increase human papillomavirus vaccine coverage: A systematic review. JAMA Pediatr. 2015;169(7): 686-692
22. Moher D, Shamseer L, Clarke M, et al; PRISMA-P Group. Preferred reporting items for systematic review and metaanalysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4: 1
23. The Guide to Community Preventive Services (The Community Guide). Available at: Www.thecommunityguide .org/index.html. Accessed September 3, 2015
24. Glasgow RE, Klesges LM, Dzewaltowski DA, Estabrooks PA, Vogt TM. Evaluating the impact of health promotion programs: Using the RE-AIM framework to form summary measures for decision making involving complex issues. Health Educ Res. 2006;21(5): 688-694
25. Jauregui E, Pacheco AM, Soltero EG, et al. Using the RE-AIM framework to evaluate physical activity public health programs in México. BMC Public Health. 2015;15: 162
26. Folta SC, Lichtenstein AH, Seguin RA, et al. The StrongWomen-Healthy Hearts program in Pennsylvania: RE-AIM analysis. Transl Behav Med. 2015;5(1): 94-102
27. Paez DC, Reis RS, Parra DC, et al. Bridging the gap between research and practice: An assessment of external validity of community-based physical activity programs in Bogotá, Colombia, and Recife, Brazil. Transl Behav Med. 2015;5(1): 1-11
28. Suryadevara M, Bonville CA, Ferraioli F, Domachowske JB. Communitycentered education improves vaccination rates in children from low-income households. Pediatrics. 2013;132(2): 319-325
29. Cates JR, Diehl SJ, Crandell JL, Coyne-Beasley T. Intervention effects from a social marketing campaign to promote HPV vaccination in preteen boys. Vaccine. 2014;32(33): 4171-4178
30. Juraskova I, Bari RA, O'Brien MT, McCaffery KJ. HPV vaccine promotion: Does referring to both cervical cancer and genital warts affect intended and actual vaccination behavior? Womens Health Issues. 2011;21(1): 71-79
31. Gerend MA, Shepherd JE. Predicting human papillomavirus vaccine uptake in young adult women: Comparing the health belief model and theory of planned behavior. Ann Behav Med. 2012;44(2): 171-180
32. Hopfer S. Effects of a narrative HPV vaccination intervention aimed at reaching college women: A randomized controlled trial. Prev Sci. 2012;13(2): 173-182
33. Wegwarth O, Kurzenhäuser-Carstens S, Gigerenzer G. Overcoming the knowledge-behavior gap: The effect of evidence-based HPV vaccination leaflets on understanding, intention, and actual vaccination decision. Vaccine. 2014;32(12): 1388-1393
34. Szilagyi PG, Humiston SG, Gallivan S, Albertin C, Sandler M, Blumkin A. Effectiveness of a citywide patient immunization navigator program on improving adolescent immunizations and preventive care visit rates. Arch Pediatr Adolesc Med. 2011;165(6): 547-553
35. Suh CA, Saville A, Daley MF, et al. Effectiveness and net cost of reminder/recall for adolescent immunizations. Pediatrics. 2012;129(6). Available at: Www.pediatrics.org/cgi/content/full/129/6/e1437
36. Patel A, Stern L, Unger Z, et al. Staying on track: A cluster randomized controlled trial of automated reminders aimed at increasing human papillomavirus vaccine completion. Vaccine. 2014;32(21): 2428-2433
37. Moss JL, Reiter PL, Dayton A, Brewer NT. Increasing adolescent immunization by webinar: A brief provider intervention at federally qualified health centers. Vaccine. 2012;30(33): 4960-4963
38. Gilkey MB, Dayton AM, Moss JL, et al. Increasing provision of adolescent vaccines in primary care: A randomized controlled trial. Pediatrics. 2014;134(2). Available at: Www.pediatrics.org/cgi/content/full/134/2/e346
39. Perkins RB, Zisblatt L, Legler A, Trucks E, Hanchate A, Gorin SS. Effectiveness of a provider-focused intervention to improve HPV vaccination rates in boys and girls. Vaccine. 2015;33(9): 1223-1229
40. Fiks AG, Grundmeier RW, Mayne S, et al. Effectiveness of decision support for families, clinicians, or both on HPV vaccine receipt. Pediatrics. 2013;131(6): 1114-1124
41. Cassidy B, Braxter B, Charron-Prochownik D, Schlenk EA. A quality improvement initiative to increase HPV vaccine rates using an educational and reminder strategy with parents of preteen girls. J Pediatr Health Care. 2014;28(2): 155-164
42. Moore GR, Crosby RA, Young A, Charnigo R. Low rates of free human papillomavirus vaccine uptake among young women. Sex Health. 2010;7(3): 287-290
43. Katz IT, Nkala B, Dietrich J, et al. A qualitative analysis of factors influencing HPV vaccine uptake in Soweto, South Africa among adolescents and their caregivers. PLoS One. 2013;8(8): E72094
44. Ogembo JG, Manga S, Nulah K, et al. Achieving high uptake of human papillomavirus vaccine in Cameroon: Lessons learned in overcoming challenges. Vaccine. 2014;32(35): 4399-4403
45. Wadhera P, Evans JL, Stein E, et al. Human papillomavirus knowledge, vaccine acceptance, and vaccine series completion among female entertainment and sex workers in Phnom Penh, Cambodia: The Young Women's Health Study. Int J STD AIDS. 2015;26(12): 893-902
46. Widgren K, Simonsen J, Valentiner-Branth P, Mølbak K. Uptake of the human papillomavirus-vaccination within the free-of-charge childhood vaccination programme in Denmark. Vaccine. 2011;29(52): 9663-9667
47. Jeannot E, Sudre P, Chastonay P. HPV vaccination coverage within 3 years of program launching (2008-2011) at Geneva State, Switzerland. Int J Public Health. 2012;57(3): 629-632
48. McClure CA, MacSwain M-A, Morrison H, Sanford CJ. Human papillomavirus vaccine uptake in boys and girls in a school-based vaccine delivery program in Prince Edward Island, Canada. Vaccine. 2015;33(15): 1786-1790
49. Hayashi Y, Shimizu Y, Netsu S, Hanley S, Konno R. High HPV vaccination uptake rates for adolescent girls after regional governmental funding in Shiki City, Japan. Vaccine. 2012;30(37): 5547-5550
50. Abuelo CE, Levinson KL, Salmeron J, Sologuren CV, Fernandez MJV, Belinson JL. The Peru Cervical Cancer Screening Study (PERCAPS): The design and implementation of a mother/daughter screen, treat, and vaccinate program in the Peruvian jungle. J Community Health. 2014;39(3): 409-415
51. Wilson SE, Harris T, Sethi P, Fediurek J, Macdonald L, Deeks SL. Coverage from Ontario, Canada's school-based HPV vaccine program: The first three years. Vaccine. 2013;31(5): 757-762
52. Brotherton JML, Deeks SL, Campbell-Lloyd S, et al. Interim estimates of human papillomavirus vaccination coverage in the school-based program in Australia. Commun Dis Intell Q Rep. 2008;32(4): 457-461
53. Rondy M, van Lier A, van de Kassteele J, Rust L, de Melker H. Determinants for HPV vaccine uptake in the Netherlands: A multilevel study. Vaccine. 2010;28(9): 2070-2075
54. Limia A, Pachón I. Coverage of human papillomavirus vaccination during the first year of its introduction in Spain. Euro Surveill. 2011;16(21): 19873
55. Binagwaho A, Wagner CM, Gatera M, Karema C, Nutt CT, Ngabo F. Achieving high coverage in Rwanda's national human papillomavirus vaccination programme. Bull World Health Organ. 2012;90(8): 623-628
56. Botha MH, van der Merwe FH, Snyman LC, Dreyer G. The vaccine and cervical cancer screen (VACCS) project: Acceptance of human papillomavirus vaccination in a school-based programme in two provinces of South Africa. S Afr Med J. 2015;105(1): 40-43
57. Brabin L, Roberts SA, Stretch R, et al. Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: Prospective cohort study. BMJ. 2008;336(7652): 1056-1058
58. Brotherton JML, Murray SL, Hall MA, et al. Human papillomavirus vaccine coverage among female Australian adolescents: Success of the school-based approach. Med J Aust. 2013;199(9): 614-617
59. Bundy DG, Persing NM, Solomon BS, et al. Improving immunization delivery using an electronic health record: The ImmProve project. Acad Pediatr. 2013;13(5): 458-465
60. Caskey RN, Macario E, Johnson DC, Hamlish T, Alexander KA. A schoollocated vaccination adolescent pilot initiative in chicago: Lessons learned. J Pediatric Infect Dis Soc. 2013;2(3): 198-204
61. Chadenier GMC, Colzani E, Faccini M, Borriello CR, Bonazzi C. Assessment of the first HPV vaccination campaign in two northern Italian health districts. Vaccine. 2011;29(26): 4405-4408
62. Chao C, Preciado M, Slezak J, Xu L. A randomized intervention of reminder letter for human papillomavirus vaccine series completion. J Adolesc Health. 2015;56(1): 85-90
63. Daley MF, Kempe A, Pyrzanowski J, et al. School-located vaccination of adolescents with insurance billing: Cost, reimbursement, and vaccination outcomes. J Adolesc Health. 2014;54(3): 282-288
64. Fregnani JHTG, Carvalho AL, Eluf-Neto J, et al. A school-based human papillomavirus vaccination program in Barretos, Brazil: Final results of a demonstrative study. PLoS One. 2013;8(4): E62647
65. Gold R, Naleway AL, Jenkins L, et al. Completion and timing of the threedose human papillomavirus vaccine series among adolescents attending school-based health centers in Oregon. Prev Med. 2011;52(6): 456-458
66. Kempe A, Barrow J, Stokley S, et al. Effectiveness and cost of immunization recall at school-based health centers. Pediatrics. 2012;129(6). Available at: Www.pediatrics.org/cgi/content/full/129/6/e1446
67. Kharbanda EO, Stockwell MS, Fox HW, Andres R, Lara M, Rickert VI. Text message reminders to promote human papillomavirus vaccination. Vaccine. 2011;29(14): 2537-2541
68. Kury C, Kury M, Silva R, et al. Implementation of the quadrivalent vaccine against HPV in the Municipality of Campos dos Goytacazes, Brazil-A combination of strategies to increase immunization coverage and early reduction of genital warts. Trials Vaccinol. 2013;2: 19-24
69. Matheson EC, Derouin A, Gagliano M, Thompson JA, Blood-Siegfried J. Increasing HPV vaccination series completion rates via text message reminders. J Pediatr Health Care. 2014;28(4): E35-e39
70. Moodley I, Tathiah N, Mubaiwa V, Denny L. High uptake of Gardasil vaccine among 9-12-year-old schoolgirls participating in an HPV vaccination demonstration project in KwaZulu-Natal, South Africa. S Afr Med J. 2013;103(5): 318-321
71. Rickert VI, Auslander BA, Cox DS, Rosenthal SL, Rupp RE, Zimet GD. School-based HPV immunization of young adolescents: Effects of two brief health interventions. Hum Vaccin Immunother. 2015;11(2): 315-321
72. Sinka K, Kavanagh K, Gordon R, et al. Achieving high and equitable coverage of adolescent HPV vaccine in Scotland. J Epidemiol Community Health. 2014;68(1): 57-63
73. Stubbs BW, Panozzo CA, Moss JL, Reiter PL, Whitesell DH, Brewer NT. Evaluation of an intervention providing HPV vaccine in schools. Am J Health Behav. 2014;38(1): 92-102
74. Szilagyi PG, Albertin C, Humiston SG, et al. A randomized trial of the effect of centralized reminder/recall on immunizations and preventive care visits for adolescents. Acad Pediatr. 2013;13(3): 204-213
75. Vanderpool RC, Casey BR, Crosby RA. HPV-related risk perceptions and HPV vaccine uptake among a sample of young rural women. J Community Health. 2011;36(6): 903-909
76. Watson-Jones D, Baisley K, Ponsiano R, et al. HPV vaccination in Tanzanian schoolgirls: Cluster-randomised trial comparing two vaccine delivery strategies. J Infect Dis. 2012;206(5): 678-686
77. LaMontagne DS, Barge S, Le NT, et al. Human papillomavirus vaccine delivery strategies that achieved high coverage in low-And middle-income countries. Bull World Health Organ. 2011;89(11): 821-830B
78. Navarrete J, Padilla M, Castro L, Rivera J. Development of a community pharmacy human papillomavirus vaccine program for under-insured university students along the United States/Mexico border. J Am Pharm Assoc (2003). 2014;54(6): 642-647
79. Centers for Disease Control and Prevention. Overview of AFIX. Available at: Www.cdc.gov/vaccines/programs/afix/about/overview.html. Accessed September 5, 2015
80. Cox DS, Cox AD, Sturm L, Zimet G. Behavioral interventions to increase HPV vaccination acceptability among mothers of young girls. Health Psychol. 2010;29(1): 29-39
81. Kreimer AR, Struyf F, Del Rosario-Raymundo MR, et al; Costa Rica Vaccine Trial Study Group Authors; PATRICIA Study Group Authors; HPV PATRICIA Principal Investigators/Co-Principal Investigator Collaborators; GSK Vaccines Clinical Study Support Group. Efficacy of fewer than three doses of an HPV-16/18 AS04-Adjuvanted vaccine: Combined analysis of data from the Costa Rica Vaccine and PATRICIA Trials. Lancet Oncol. 2015;16(7): 775-786
82. Centers for Disease Control and Prevention. 2014 NIS Teen Vaccination Coverage Table Data. Available at: Www.cdc.gov/vaccines/imz-managers/coverage/nis/teen/data/tables-2014.html#overall. Accessed September 12, 2015